Butylphthalide for chemo brain fog after paclitaxel or platinum chemo
Part of Mental health clinical trials.
This trial tests a medicine called butylphthalide (a brain-protecting drug) to see if it can help with memory and thinking problems that some people have after chemotherapy. It is for people who received paclitaxel or platinum chemo and are now cancer-free but still struggling with 'chemo brain' symptoms like forgetfulness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were treated with a specific type of chemotherapy (paclitaxel or platinum drugs) and no other chemo drugs.
- You have finished cancer treatment and are considered cured (except for hormone therapy you may still be taking).
- You have had memory or thinking problems for at least 3 months that started after chemo.
- You are between 35 and 80 years old and speak Chinese fluently.
- You do not have dementia, Alzheimer's, or other known causes of memory loss.
- You have not had a stroke, brain tumor, or serious head injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether butyphthalide can help thinking and memory improve after an acute ischemic stroke. It compares people who take the study medicine versus usual care, and measures cognitive (thinking) changes over follow-up.
This study tests whether a medicine called butylphthalide can help improve memory and thinking in older adults with focal epilepsy who already have mild cognitive issues. It aims to find a new way to support brain health in people with epilepsy.
This trial tests if butylphthalide, a medicine given by mouth, can help prevent long-term thinking and memory problems after a minor stroke. It is for people who had a very mild stroke and enrolled soon after.
This trial tests if a sublingual tablet can help people who have memory and thinking problems related to chemotherapy. If you have had certain types of chemotherapy and now notice trouble with your memory or concentration, this treatment might help improve your symptoms.
This trial tests if butylphthalide, a drug that may improve blood flow, helps people with a narrowed artery in the brain (the middle cerebral artery) after a recent stroke or mini-stroke. It is for people aged 55-75 with at least one risk factor like high blood pressure or diabetes.
This trial is studying whether a combination of chemotherapy (carboplatin and paclitaxel) and an immunotherapy drug (anti-PD-1) affects memory and thinking in people with head and neck cancer that can be removed with surgery. Researchers want to see if these treatments cause any cognitive changes.
Hear when a new Chemotherapy-Related Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.